| 标题 |
Abstract B130: Phase 1 study of Zanidatamab Zovodotin (ZW49): Safety Profile and Recommended Dose (RD) in patients with Human Epidermal Growth Factor 2 (HER2)-positive solid cancers |
| 网址 | |
| DOI | |
| 其它 |
期刊:Molecular Cancer Therapeutics 作者:Do-Youn Oh; Philippe L Bedard; Keun-Wook Lee; Hyo Sook Han; Yoon-Koo Kang; et al 出版日期:2023-12-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)